nodes	percent_of_prediction	percent_of_DWPC	metapath
Amprenavir—Cytochrome P450 3A4 Inhibitors—Ticagrelor—coronary artery disease	0.434	1	CiPCiCtD
Amprenavir—CYP2C19—coronary artery disease	0.102	1	CbGaD
Amprenavir—ABCC1—Rosuvastatin—coronary artery disease	0.0133	0.0378	CbGbCtD
Amprenavir—ABCC1—Atorvastatin—coronary artery disease	0.011	0.0313	CbGbCtD
Amprenavir—CYP2C8—Fenofibrate—coronary artery disease	0.0106	0.0301	CbGbCtD
Amprenavir—CYP2B6—Clopidogrel—coronary artery disease	0.00972	0.0276	CbGbCtD
Amprenavir—CYP2C8—Gemfibrozil—coronary artery disease	0.00849	0.0241	CbGbCtD
Amprenavir—ABCB1—Ticagrelor—coronary artery disease	0.00807	0.0229	CbGbCtD
Amprenavir—CYP3A5—Clopidogrel—coronary artery disease	0.00766	0.0217	CbGbCtD
Amprenavir—CYP2C9—Fenofibrate—coronary artery disease	0.00741	0.021	CbGbCtD
Amprenavir—CYP2C8—Clopidogrel—coronary artery disease	0.00736	0.0209	CbGbCtD
Amprenavir—CYP2C19—Gemfibrozil—coronary artery disease	0.00712	0.0202	CbGbCtD
Amprenavir—CYP3A5—Eplerenone—coronary artery disease	0.00712	0.0202	CbGbCtD
Amprenavir—CYP2C8—Pitavastatin—coronary artery disease	0.00643	0.0183	CbGbCtD
Amprenavir—CYP2C19—Clopidogrel—coronary artery disease	0.00618	0.0175	CbGbCtD
Amprenavir—CYP2C9—Gemfibrozil—coronary artery disease	0.00592	0.0168	CbGbCtD
Amprenavir—CYP2B6—Simvastatin—coronary artery disease	0.00582	0.0165	CbGbCtD
Amprenavir—CYP2C19—Telmisartan—coronary artery disease	0.0054	0.0153	CbGbCtD
Amprenavir—CYP2B6—Atorvastatin—coronary artery disease	0.00519	0.0147	CbGbCtD
Amprenavir—CYP2C9—Clopidogrel—coronary artery disease	0.00513	0.0146	CbGbCtD
Amprenavir—ABCB1—Clopidogrel—coronary artery disease	0.00498	0.0141	CbGbCtD
Amprenavir—ABCB1—Perindopril—coronary artery disease	0.00498	0.0141	CbGbCtD
Amprenavir—CYP3A5—Rosuvastatin—coronary artery disease	0.00493	0.014	CbGbCtD
Amprenavir—CYP3A4—Ticagrelor—coronary artery disease	0.00483	0.0137	CbGbCtD
Amprenavir—CYP2C8—Acetylsalicylic acid—coronary artery disease	0.00462	0.0131	CbGbCtD
Amprenavir—CYP3A5—Simvastatin—coronary artery disease	0.00459	0.013	CbGbCtD
Amprenavir—CYP3A5—Pravastatin—coronary artery disease	0.00449	0.0127	CbGbCtD
Amprenavir—CYP3A5—Lovastatin—coronary artery disease	0.00449	0.0127	CbGbCtD
Amprenavir—CYP2C9—Pitavastatin—coronary artery disease	0.00449	0.0127	CbGbCtD
Amprenavir—CYP2C8—Simvastatin—coronary artery disease	0.00441	0.0125	CbGbCtD
Amprenavir—CYP2C9—Valsartan—coronary artery disease	0.00437	0.0124	CbGbCtD
Amprenavir—ABCB1—Telmisartan—coronary artery disease	0.00436	0.0124	CbGbCtD
Amprenavir—ABCB1—Pitavastatin—coronary artery disease	0.00436	0.0124	CbGbCtD
Amprenavir—CYP2C19—Timolol—coronary artery disease	0.00435	0.0123	CbGbCtD
Amprenavir—CYP2C8—Pravastatin—coronary artery disease	0.00432	0.0122	CbGbCtD
Amprenavir—CYP2C8—Lovastatin—coronary artery disease	0.00432	0.0122	CbGbCtD
Amprenavir—CYP3A4—Fenofibrate—coronary artery disease	0.00431	0.0122	CbGbCtD
Amprenavir—ABCB1—Enalapril—coronary artery disease	0.00413	0.0117	CbGbCtD
Amprenavir—ABCB1—Lisinopril—coronary artery disease	0.00413	0.0117	CbGbCtD
Amprenavir—CYP3A5—Atorvastatin—coronary artery disease	0.00409	0.0116	CbGbCtD
Amprenavir—CYP2C19—Rosuvastatin—coronary artery disease	0.00398	0.0113	CbGbCtD
Amprenavir—CYP2C8—Atorvastatin—coronary artery disease	0.00393	0.0112	CbGbCtD
Amprenavir—CYP2C19—Acetylsalicylic acid—coronary artery disease	0.00388	0.011	CbGbCtD
Amprenavir—CYP3A5—Losartan—coronary artery disease	0.00374	0.0106	CbGbCtD
Amprenavir—CYP2C19—Simvastatin—coronary artery disease	0.0037	0.0105	CbGbCtD
Amprenavir—CYP2C19—Lovastatin—coronary artery disease	0.00362	0.0103	CbGbCtD
Amprenavir—CYP2C8—Losartan—coronary artery disease	0.0036	0.0102	CbGbCtD
Amprenavir—CYP2D6—Niacin—coronary artery disease	0.00356	0.0101	CbGbCtD
Amprenavir—ABCB1—Timolol—coronary artery disease	0.00351	0.00996	CbGbCtD
Amprenavir—CYP3A4—Gemfibrozil—coronary artery disease	0.00344	0.00977	CbGbCtD
Amprenavir—CYP2C9—Rosuvastatin—coronary artery disease	0.00331	0.00939	CbGbCtD
Amprenavir—CYP2D6—Timolol—coronary artery disease	0.00331	0.00938	CbGbCtD
Amprenavir—CYP2C19—Atorvastatin—coronary artery disease	0.0033	0.00935	CbGbCtD
Amprenavir—CYP2C9—Acetylsalicylic acid—coronary artery disease	0.00322	0.00915	CbGbCtD
Amprenavir—ABCB1—Ezetimibe—coronary artery disease	0.00321	0.00911	CbGbCtD
Amprenavir—ABCB1—Acetylsalicylic acid—coronary artery disease	0.00313	0.00888	CbGbCtD
Amprenavir—ABCB1—Captopril—coronary artery disease	0.00309	0.00877	CbGbCtD
Amprenavir—CYP2C9—Simvastatin—coronary artery disease	0.00308	0.00873	CbGbCtD
Amprenavir—CYP2C19—Losartan—coronary artery disease	0.00302	0.00856	CbGbCtD
Amprenavir—CYP2C9—Pravastatin—coronary artery disease	0.00301	0.00854	CbGbCtD
Amprenavir—CYP2C9—Lovastatin—coronary artery disease	0.00301	0.00854	CbGbCtD
Amprenavir—CYP3A4—Clopidogrel—coronary artery disease	0.00299	0.00847	CbGbCtD
Amprenavir—ABCB1—Simvastatin—coronary artery disease	0.00299	0.00847	CbGbCtD
Amprenavir—ABCB1—Lovastatin—coronary artery disease	0.00292	0.00829	CbGbCtD
Amprenavir—ABCB1—Pravastatin—coronary artery disease	0.00292	0.00829	CbGbCtD
Amprenavir—CYP2D6—Captopril—coronary artery disease	0.00291	0.00826	CbGbCtD
Amprenavir—CYP2D6—Simvastatin—coronary artery disease	0.00281	0.00798	CbGbCtD
Amprenavir—CYP3A4—Eplerenone—coronary artery disease	0.00278	0.00787	CbGbCtD
Amprenavir—CYP2D6—Pravastatin—coronary artery disease	0.00275	0.00781	CbGbCtD
Amprenavir—CYP2D6—Lovastatin—coronary artery disease	0.00275	0.00781	CbGbCtD
Amprenavir—CYP2C9—Atorvastatin—coronary artery disease	0.00274	0.00778	CbGbCtD
Amprenavir—ABCB1—Atorvastatin—coronary artery disease	0.00266	0.00755	CbGbCtD
Amprenavir—CYP2C9—Losartan—coronary artery disease	0.00251	0.00711	CbGbCtD
Amprenavir—CYP2D6—Atorvastatin—coronary artery disease	0.00251	0.00711	CbGbCtD
Amprenavir—CYP3A4—Enalapril—coronary artery disease	0.00247	0.00702	CbGbCtD
Amprenavir—ABCB1—Losartan—coronary artery disease	0.00243	0.0069	CbGbCtD
Amprenavir—CYP3A4—Ezetimibe—coronary artery disease	0.00192	0.00546	CbGbCtD
Amprenavir—CYP3A4—Rosuvastatin—coronary artery disease	0.00192	0.00546	CbGbCtD
Amprenavir—CYP3A4—Simvastatin—coronary artery disease	0.00179	0.00507	CbGbCtD
Amprenavir—CYP3A4—Pravastatin—coronary artery disease	0.00175	0.00497	CbGbCtD
Amprenavir—CYP3A4—Lovastatin—coronary artery disease	0.00175	0.00497	CbGbCtD
Amprenavir—CYP3A4—Atorvastatin—coronary artery disease	0.00159	0.00452	CbGbCtD
Amprenavir—CYP3A4—Losartan—coronary artery disease	0.00146	0.00414	CbGbCtD
Amprenavir—CYP2C9—cardial valve—coronary artery disease	6.69e-05	0.533	CbGeAlD
Amprenavir—Pruritus—Clopidogrel—coronary artery disease	6.67e-05	0.000793	CcSEcCtD
Amprenavir—Decreased appetite—Enalapril—coronary artery disease	6.66e-05	0.000792	CcSEcCtD
Amprenavir—Gastrointestinal disorder—Trandolapril—coronary artery disease	6.64e-05	0.00079	CcSEcCtD
Amprenavir—Fatigue—Trandolapril—coronary artery disease	6.63e-05	0.000789	CcSEcCtD
Amprenavir—Pruritus—Lovastatin—coronary artery disease	6.62e-05	0.000788	CcSEcCtD
Amprenavir—Anorexia—Furosemide—coronary artery disease	6.61e-05	0.000786	CcSEcCtD
Amprenavir—Fatigue—Enalapril—coronary artery disease	6.6e-05	0.000786	CcSEcCtD
Amprenavir—Paraesthesia—Captopril—coronary artery disease	6.6e-05	0.000785	CcSEcCtD
Amprenavir—Asthenia—Ezetimibe—coronary artery disease	6.59e-05	0.000784	CcSEcCtD
Amprenavir—Tremor—Ramipril—coronary artery disease	6.58e-05	0.000783	CcSEcCtD
Amprenavir—Gastrointestinal pain—Niacin—coronary artery disease	6.58e-05	0.000782	CcSEcCtD
Amprenavir—Decreased appetite—Telmisartan—coronary artery disease	6.57e-05	0.000781	CcSEcCtD
Amprenavir—Nausea—Rosuvastatin—coronary artery disease	6.56e-05	0.000781	CcSEcCtD
Amprenavir—Diarrhoea—Fenofibrate—coronary artery disease	6.56e-05	0.000781	CcSEcCtD
Amprenavir—Nervous system disorder—Losartan—coronary artery disease	6.56e-05	0.00078	CcSEcCtD
Amprenavir—Abdominal pain—Valsartan—coronary artery disease	6.54e-05	0.000778	CcSEcCtD
Amprenavir—Gastrointestinal disorder—Telmisartan—coronary artery disease	6.52e-05	0.000776	CcSEcCtD
Amprenavir—Fatigue—Telmisartan—coronary artery disease	6.51e-05	0.000775	CcSEcCtD
Amprenavir—Abdominal pain—Olmesartan—coronary artery disease	6.51e-05	0.000774	CcSEcCtD
Amprenavir—Pruritus—Ezetimibe—coronary artery disease	6.5e-05	0.000773	CcSEcCtD
Amprenavir—Musculoskeletal discomfort—Perindopril—coronary artery disease	6.5e-05	0.000773	CcSEcCtD
Amprenavir—Gastrointestinal pain—Pravastatin—coronary artery disease	6.47e-05	0.00077	CcSEcCtD
Amprenavir—Diarrhoea—Clopidogrel—coronary artery disease	6.45e-05	0.000767	CcSEcCtD
Amprenavir—Asthenia—Eplerenone—coronary artery disease	6.45e-05	0.000767	CcSEcCtD
Amprenavir—Angioedema—Ramipril—coronary artery disease	6.42e-05	0.000764	CcSEcCtD
Amprenavir—Mental disorder—Lisinopril—coronary artery disease	6.41e-05	0.000763	CcSEcCtD
Amprenavir—Diarrhoea—Lovastatin—coronary artery disease	6.41e-05	0.000762	CcSEcCtD
Amprenavir—Paraesthesia—Perindopril—coronary artery disease	6.4e-05	0.000762	CcSEcCtD
Amprenavir—Decreased appetite—Captopril—coronary artery disease	6.39e-05	0.00076	CcSEcCtD
Amprenavir—Anorexia—Losartan—coronary artery disease	6.38e-05	0.000759	CcSEcCtD
Amprenavir—Nausea—Acetylsalicylic acid—coronary artery disease	6.38e-05	0.000759	CcSEcCtD
Amprenavir—Malnutrition—Lisinopril—coronary artery disease	6.37e-05	0.000758	CcSEcCtD
Amprenavir—Pruritus—Eplerenone—coronary artery disease	6.36e-05	0.000757	CcSEcCtD
Amprenavir—Abdominal pain—Niacin—coronary artery disease	6.36e-05	0.000756	CcSEcCtD
Amprenavir—Fatigue—Captopril—coronary artery disease	6.33e-05	0.000753	CcSEcCtD
Amprenavir—Gastrointestinal pain—Trandolapril—coronary artery disease	6.29e-05	0.000748	CcSEcCtD
Amprenavir—Asthenia—Simvastatin—coronary artery disease	6.28e-05	0.000748	CcSEcCtD
Amprenavir—Diarrhoea—Ezetimibe—coronary artery disease	6.28e-05	0.000748	CcSEcCtD
Amprenavir—Flatulence—Lisinopril—coronary artery disease	6.28e-05	0.000747	CcSEcCtD
Amprenavir—Angioedema—Timolol—coronary artery disease	6.28e-05	0.000747	CcSEcCtD
Amprenavir—Gastrointestinal pain—Enalapril—coronary artery disease	6.26e-05	0.000745	CcSEcCtD
Amprenavir—Abdominal pain—Pravastatin—coronary artery disease	6.26e-05	0.000745	CcSEcCtD
Amprenavir—Paraesthesia—Furosemide—coronary artery disease	6.23e-05	0.000741	CcSEcCtD
Amprenavir—Decreased appetite—Perindopril—coronary artery disease	6.2e-05	0.000738	CcSEcCtD
Amprenavir—Pruritus—Simvastatin—coronary artery disease	6.2e-05	0.000737	CcSEcCtD
Amprenavir—Gastrointestinal pain—Telmisartan—coronary artery disease	6.18e-05	0.000735	CcSEcCtD
Amprenavir—Gastrointestinal disorder—Perindopril—coronary artery disease	6.16e-05	0.000733	CcSEcCtD
Amprenavir—Diarrhoea—Eplerenone—coronary artery disease	6.15e-05	0.000732	CcSEcCtD
Amprenavir—Fatigue—Perindopril—coronary artery disease	6.15e-05	0.000732	CcSEcCtD
Amprenavir—Vomiting—Fenofibrate—coronary artery disease	6.1e-05	0.000725	CcSEcCtD
Amprenavir—Musculoskeletal discomfort—Losartan—coronary artery disease	6.09e-05	0.000725	CcSEcCtD
Amprenavir—Abdominal pain—Trandolapril—coronary artery disease	6.08e-05	0.000723	CcSEcCtD
Amprenavir—Abdominal pain—Enalapril—coronary artery disease	6.05e-05	0.00072	CcSEcCtD
Amprenavir—Rash—Fenofibrate—coronary artery disease	6.05e-05	0.000719	CcSEcCtD
Amprenavir—Dermatitis—Fenofibrate—coronary artery disease	6.04e-05	0.000719	CcSEcCtD
Amprenavir—Decreased appetite—Furosemide—coronary artery disease	6.03e-05	0.000717	CcSEcCtD
Amprenavir—Headache—Fenofibrate—coronary artery disease	6.01e-05	0.000715	CcSEcCtD
Amprenavir—Paraesthesia—Losartan—coronary artery disease	6.01e-05	0.000715	CcSEcCtD
Amprenavir—Gastrointestinal pain—Captopril—coronary artery disease	6.01e-05	0.000715	CcSEcCtD
Amprenavir—Vomiting—Clopidogrel—coronary artery disease	5.99e-05	0.000713	CcSEcCtD
Amprenavir—Diarrhoea—Simvastatin—coronary artery disease	5.99e-05	0.000713	CcSEcCtD
Amprenavir—Gastrointestinal disorder—Furosemide—coronary artery disease	5.99e-05	0.000712	CcSEcCtD
Amprenavir—Myalgia—Ramipril—coronary artery disease	5.98e-05	0.000712	CcSEcCtD
Amprenavir—Fatigue—Furosemide—coronary artery disease	5.98e-05	0.000711	CcSEcCtD
Amprenavir—Tremor—Lisinopril—coronary artery disease	5.97e-05	0.00071	CcSEcCtD
Amprenavir—Abdominal pain—Telmisartan—coronary artery disease	5.97e-05	0.00071	CcSEcCtD
Amprenavir—Vomiting—Lovastatin—coronary artery disease	5.95e-05	0.000708	CcSEcCtD
Amprenavir—Rash—Clopidogrel—coronary artery disease	5.94e-05	0.000707	CcSEcCtD
Amprenavir—Unspecified disorder of skin and subcutaneous tissue—Ramipril—coronary artery disease	5.94e-05	0.000707	CcSEcCtD
Amprenavir—Dermatitis—Clopidogrel—coronary artery disease	5.94e-05	0.000706	CcSEcCtD
Amprenavir—Asthenia—Valsartan—coronary artery disease	5.93e-05	0.000706	CcSEcCtD
Amprenavir—Discomfort—Ramipril—coronary artery disease	5.91e-05	0.000703	CcSEcCtD
Amprenavir—Asthenia—Olmesartan—coronary artery disease	5.91e-05	0.000703	CcSEcCtD
Amprenavir—Headache—Clopidogrel—coronary artery disease	5.91e-05	0.000703	CcSEcCtD
Amprenavir—Rash—Lovastatin—coronary artery disease	5.9e-05	0.000702	CcSEcCtD
Amprenavir—Dermatitis—Lovastatin—coronary artery disease	5.9e-05	0.000702	CcSEcCtD
Amprenavir—Headache—Lovastatin—coronary artery disease	5.87e-05	0.000698	CcSEcCtD
Amprenavir—Pruritus—Valsartan—coronary artery disease	5.85e-05	0.000696	CcSEcCtD
Amprenavir—Myalgia—Timolol—coronary artery disease	5.85e-05	0.000696	CcSEcCtD
Amprenavir—Vomiting—Ezetimibe—coronary artery disease	5.84e-05	0.000695	CcSEcCtD
Amprenavir—Gastrointestinal pain—Perindopril—coronary artery disease	5.83e-05	0.000694	CcSEcCtD
Amprenavir—Angioedema—Lisinopril—coronary artery disease	5.82e-05	0.000693	CcSEcCtD
Amprenavir—Pruritus—Olmesartan—coronary artery disease	5.82e-05	0.000693	CcSEcCtD
Amprenavir—Decreased appetite—Losartan—coronary artery disease	5.82e-05	0.000692	CcSEcCtD
Amprenavir—Unspecified disorder of skin and subcutaneous tissue—Timolol—coronary artery disease	5.81e-05	0.000691	CcSEcCtD
Amprenavir—Abdominal pain—Captopril—coronary artery disease	5.81e-05	0.000691	CcSEcCtD
Amprenavir—Rash—Ezetimibe—coronary artery disease	5.79e-05	0.000689	CcSEcCtD
Amprenavir—Dermatitis—Ezetimibe—coronary artery disease	5.79e-05	0.000688	CcSEcCtD
Amprenavir—Discomfort—Timolol—coronary artery disease	5.78e-05	0.000688	CcSEcCtD
Amprenavir—Asthenia—Niacin—coronary artery disease	5.77e-05	0.000686	CcSEcCtD
Amprenavir—Fatigue—Losartan—coronary artery disease	5.77e-05	0.000686	CcSEcCtD
Amprenavir—Headache—Ezetimibe—coronary artery disease	5.75e-05	0.000685	CcSEcCtD
Amprenavir—Vomiting—Eplerenone—coronary artery disease	5.72e-05	0.00068	CcSEcCtD
Amprenavir—Nausea—Fenofibrate—coronary artery disease	5.7e-05	0.000678	CcSEcCtD
Amprenavir—Pruritus—Niacin—coronary artery disease	5.69e-05	0.000677	CcSEcCtD
Amprenavir—Asthenia—Pravastatin—coronary artery disease	5.68e-05	0.000676	CcSEcCtD
Amprenavir—Gastrointestinal pain—Furosemide—coronary artery disease	5.67e-05	0.000674	CcSEcCtD
Amprenavir—Rash—Eplerenone—coronary artery disease	5.67e-05	0.000674	CcSEcCtD
Amprenavir—Dermatitis—Eplerenone—coronary artery disease	5.66e-05	0.000674	CcSEcCtD
Amprenavir—Diarrhoea—Valsartan—coronary artery disease	5.66e-05	0.000673	CcSEcCtD
Amprenavir—Abdominal pain—Perindopril—coronary artery disease	5.64e-05	0.000671	CcSEcCtD
Amprenavir—Diarrhoea—Olmesartan—coronary artery disease	5.63e-05	0.00067	CcSEcCtD
Amprenavir—Headache—Eplerenone—coronary artery disease	5.63e-05	0.00067	CcSEcCtD
Amprenavir—Nervous system disorder—Ramipril—coronary artery disease	5.63e-05	0.000669	CcSEcCtD
Amprenavir—Pruritus—Pravastatin—coronary artery disease	5.6e-05	0.000667	CcSEcCtD
Amprenavir—Nausea—Clopidogrel—coronary artery disease	5.6e-05	0.000666	CcSEcCtD
Amprenavir—Skin disorder—Ramipril—coronary artery disease	5.57e-05	0.000663	CcSEcCtD
Amprenavir—Vomiting—Simvastatin—coronary artery disease	5.57e-05	0.000663	CcSEcCtD
Amprenavir—Nausea—Lovastatin—coronary artery disease	5.56e-05	0.000662	CcSEcCtD
Amprenavir—Rash—Simvastatin—coronary artery disease	5.52e-05	0.000657	CcSEcCtD
Amprenavir—Dermatitis—Simvastatin—coronary artery disease	5.52e-05	0.000656	CcSEcCtD
Amprenavir—Asthenia—Trandolapril—coronary artery disease	5.52e-05	0.000656	CcSEcCtD
Amprenavir—Diarrhoea—Niacin—coronary artery disease	5.5e-05	0.000655	CcSEcCtD
Amprenavir—Nervous system disorder—Timolol—coronary artery disease	5.5e-05	0.000654	CcSEcCtD
Amprenavir—Asthenia—Enalapril—coronary artery disease	5.49e-05	0.000654	CcSEcCtD
Amprenavir—Headache—Simvastatin—coronary artery disease	5.49e-05	0.000653	CcSEcCtD
Amprenavir—Abdominal pain—Furosemide—coronary artery disease	5.48e-05	0.000652	CcSEcCtD
Amprenavir—Gastrointestinal pain—Losartan—coronary artery disease	5.47e-05	0.000651	CcSEcCtD
Amprenavir—Anorexia—Ramipril—coronary artery disease	5.47e-05	0.00065	CcSEcCtD
Amprenavir—Nausea—Ezetimibe—coronary artery disease	5.46e-05	0.000649	CcSEcCtD
Amprenavir—Skin disorder—Timolol—coronary artery disease	5.45e-05	0.000648	CcSEcCtD
Amprenavir—Pruritus—Trandolapril—coronary artery disease	5.44e-05	0.000647	CcSEcCtD
Amprenavir—Myalgia—Lisinopril—coronary artery disease	5.43e-05	0.000646	CcSEcCtD
Amprenavir—Asthenia—Telmisartan—coronary artery disease	5.42e-05	0.000645	CcSEcCtD
Amprenavir—Pruritus—Enalapril—coronary artery disease	5.42e-05	0.000645	CcSEcCtD
Amprenavir—Diarrhoea—Pravastatin—coronary artery disease	5.42e-05	0.000645	CcSEcCtD
Amprenavir—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—coronary artery disease	5.39e-05	0.000641	CcSEcCtD
Amprenavir—Discomfort—Lisinopril—coronary artery disease	5.36e-05	0.000638	CcSEcCtD
Amprenavir—Anorexia—Timolol—coronary artery disease	5.35e-05	0.000636	CcSEcCtD
Amprenavir—Pruritus—Telmisartan—coronary artery disease	5.34e-05	0.000636	CcSEcCtD
Amprenavir—Nausea—Eplerenone—coronary artery disease	5.34e-05	0.000635	CcSEcCtD
Amprenavir—Abdominal pain—Losartan—coronary artery disease	5.29e-05	0.000629	CcSEcCtD
Amprenavir—Asthenia—Captopril—coronary artery disease	5.27e-05	0.000627	CcSEcCtD
Amprenavir—Diarrhoea—Trandolapril—coronary artery disease	5.26e-05	0.000626	CcSEcCtD
Amprenavir—Vomiting—Valsartan—coronary artery disease	5.26e-05	0.000626	CcSEcCtD
Amprenavir—Diarrhoea—Enalapril—coronary artery disease	5.24e-05	0.000623	CcSEcCtD
Amprenavir—Vomiting—Olmesartan—coronary artery disease	5.23e-05	0.000623	CcSEcCtD
Amprenavir—Musculoskeletal discomfort—Ramipril—coronary artery disease	5.23e-05	0.000622	CcSEcCtD
Amprenavir—Rash—Valsartan—coronary artery disease	5.22e-05	0.00062	CcSEcCtD
Amprenavir—Dermatitis—Valsartan—coronary artery disease	5.21e-05	0.00062	CcSEcCtD
Amprenavir—Nausea—Simvastatin—coronary artery disease	5.2e-05	0.000619	CcSEcCtD
Amprenavir—Pruritus—Captopril—coronary artery disease	5.2e-05	0.000618	CcSEcCtD
Amprenavir—Rash—Olmesartan—coronary artery disease	5.19e-05	0.000617	CcSEcCtD
Amprenavir—Dermatitis—Olmesartan—coronary artery disease	5.19e-05	0.000617	CcSEcCtD
Amprenavir—Headache—Valsartan—coronary artery disease	5.18e-05	0.000616	CcSEcCtD
Amprenavir—Diarrhoea—Telmisartan—coronary artery disease	5.17e-05	0.000615	CcSEcCtD
Amprenavir—Headache—Olmesartan—coronary artery disease	5.16e-05	0.000614	CcSEcCtD
Amprenavir—Paraesthesia—Ramipril—coronary artery disease	5.15e-05	0.000613	CcSEcCtD
Amprenavir—Asthenia—Perindopril—coronary artery disease	5.12e-05	0.000609	CcSEcCtD
Amprenavir—Vomiting—Niacin—coronary artery disease	5.11e-05	0.000608	CcSEcCtD
Amprenavir—Musculoskeletal discomfort—Timolol—coronary artery disease	5.11e-05	0.000608	CcSEcCtD
Amprenavir—Rash—Niacin—coronary artery disease	5.07e-05	0.000603	CcSEcCtD
Amprenavir—Dermatitis—Niacin—coronary artery disease	5.07e-05	0.000603	CcSEcCtD
Amprenavir—Skin disorder—Lisinopril—coronary artery disease	5.05e-05	0.000601	CcSEcCtD
Amprenavir—Pruritus—Perindopril—coronary artery disease	5.05e-05	0.0006	CcSEcCtD
Amprenavir—Headache—Niacin—coronary artery disease	5.04e-05	0.000599	CcSEcCtD
Amprenavir—Paraesthesia—Timolol—coronary artery disease	5.04e-05	0.000599	CcSEcCtD
Amprenavir—Vomiting—Pravastatin—coronary artery disease	5.03e-05	0.000599	CcSEcCtD
Amprenavir—Diarrhoea—Captopril—coronary artery disease	5.03e-05	0.000598	CcSEcCtD
Amprenavir—Rash—Pravastatin—coronary artery disease	4.99e-05	0.000594	CcSEcCtD
Amprenavir—Dermatitis—Pravastatin—coronary artery disease	4.99e-05	0.000593	CcSEcCtD
Amprenavir—Decreased appetite—Ramipril—coronary artery disease	4.99e-05	0.000593	CcSEcCtD
Amprenavir—Asthenia—Furosemide—coronary artery disease	4.97e-05	0.000592	CcSEcCtD
Amprenavir—Headache—Pravastatin—coronary artery disease	4.96e-05	0.00059	CcSEcCtD
Amprenavir—Anorexia—Lisinopril—coronary artery disease	4.96e-05	0.00059	CcSEcCtD
Amprenavir—Gastrointestinal disorder—Ramipril—coronary artery disease	4.95e-05	0.000589	CcSEcCtD
Amprenavir—Fatigue—Ramipril—coronary artery disease	4.95e-05	0.000588	CcSEcCtD
Amprenavir—Nausea—Valsartan—coronary artery disease	4.91e-05	0.000585	CcSEcCtD
Amprenavir—Pruritus—Furosemide—coronary artery disease	4.91e-05	0.000584	CcSEcCtD
Amprenavir—Nausea—Olmesartan—coronary artery disease	4.89e-05	0.000582	CcSEcCtD
Amprenavir—Vomiting—Trandolapril—coronary artery disease	4.89e-05	0.000582	CcSEcCtD
Amprenavir—Diarrhoea—Perindopril—coronary artery disease	4.88e-05	0.000581	CcSEcCtD
Amprenavir—Decreased appetite—Timolol—coronary artery disease	4.87e-05	0.00058	CcSEcCtD
Amprenavir—Vomiting—Enalapril—coronary artery disease	4.87e-05	0.000579	CcSEcCtD
Amprenavir—Rash—Trandolapril—coronary artery disease	4.85e-05	0.000577	CcSEcCtD
Amprenavir—Dermatitis—Trandolapril—coronary artery disease	4.84e-05	0.000576	CcSEcCtD
Amprenavir—Gastrointestinal disorder—Timolol—coronary artery disease	4.84e-05	0.000576	CcSEcCtD
Amprenavir—Fatigue—Timolol—coronary artery disease	4.83e-05	0.000575	CcSEcCtD
Amprenavir—Rash—Enalapril—coronary artery disease	4.83e-05	0.000575	CcSEcCtD
Amprenavir—Dermatitis—Enalapril—coronary artery disease	4.82e-05	0.000574	CcSEcCtD
Amprenavir—Headache—Trandolapril—coronary artery disease	4.82e-05	0.000573	CcSEcCtD
Amprenavir—Vomiting—Telmisartan—coronary artery disease	4.8e-05	0.000571	CcSEcCtD
Amprenavir—Asthenia—Losartan—coronary artery disease	4.8e-05	0.000571	CcSEcCtD
Amprenavir—Headache—Enalapril—coronary artery disease	4.8e-05	0.000571	CcSEcCtD
Amprenavir—Nausea—Niacin—coronary artery disease	4.78e-05	0.000568	CcSEcCtD
Amprenavir—Rash—Telmisartan—coronary artery disease	4.76e-05	0.000567	CcSEcCtD
Amprenavir—Dermatitis—Telmisartan—coronary artery disease	4.76e-05	0.000566	CcSEcCtD
Amprenavir—Diarrhoea—Furosemide—coronary artery disease	4.74e-05	0.000564	CcSEcCtD
Amprenavir—Musculoskeletal discomfort—Lisinopril—coronary artery disease	4.74e-05	0.000564	CcSEcCtD
Amprenavir—Pruritus—Losartan—coronary artery disease	4.73e-05	0.000563	CcSEcCtD
Amprenavir—Headache—Telmisartan—coronary artery disease	4.73e-05	0.000563	CcSEcCtD
Amprenavir—Nausea—Pravastatin—coronary artery disease	4.7e-05	0.00056	CcSEcCtD
Amprenavir—Gastrointestinal pain—Ramipril—coronary artery disease	4.69e-05	0.000558	CcSEcCtD
Amprenavir—Paraesthesia—Lisinopril—coronary artery disease	4.67e-05	0.000556	CcSEcCtD
Amprenavir—Vomiting—Captopril—coronary artery disease	4.67e-05	0.000556	CcSEcCtD
Amprenavir—Rash—Captopril—coronary artery disease	4.63e-05	0.000551	CcSEcCtD
Amprenavir—Dermatitis—Captopril—coronary artery disease	4.63e-05	0.000551	CcSEcCtD
Amprenavir—Headache—Captopril—coronary artery disease	4.6e-05	0.000547	CcSEcCtD
Amprenavir—Gastrointestinal pain—Timolol—coronary artery disease	4.59e-05	0.000546	CcSEcCtD
Amprenavir—Diarrhoea—Losartan—coronary artery disease	4.58e-05	0.000545	CcSEcCtD
Amprenavir—Nausea—Trandolapril—coronary artery disease	4.57e-05	0.000543	CcSEcCtD
Amprenavir—Nausea—Enalapril—coronary artery disease	4.55e-05	0.000541	CcSEcCtD
Amprenavir—Vomiting—Perindopril—coronary artery disease	4.53e-05	0.000539	CcSEcCtD
Amprenavir—Abdominal pain—Ramipril—coronary artery disease	4.53e-05	0.000539	CcSEcCtD
Amprenavir—Decreased appetite—Lisinopril—coronary artery disease	4.52e-05	0.000538	CcSEcCtD
Amprenavir—Rash—Perindopril—coronary artery disease	4.5e-05	0.000535	CcSEcCtD
Amprenavir—Dermatitis—Perindopril—coronary artery disease	4.49e-05	0.000534	CcSEcCtD
Amprenavir—Gastrointestinal disorder—Lisinopril—coronary artery disease	4.49e-05	0.000534	CcSEcCtD
Amprenavir—Nausea—Telmisartan—coronary artery disease	4.49e-05	0.000534	CcSEcCtD
Amprenavir—Fatigue—Lisinopril—coronary artery disease	4.48e-05	0.000534	CcSEcCtD
Amprenavir—Headache—Perindopril—coronary artery disease	4.47e-05	0.000532	CcSEcCtD
Amprenavir—Abdominal pain—Timolol—coronary artery disease	4.43e-05	0.000527	CcSEcCtD
Amprenavir—Vomiting—Furosemide—coronary artery disease	4.41e-05	0.000524	CcSEcCtD
Amprenavir—Rash—Furosemide—coronary artery disease	4.37e-05	0.00052	CcSEcCtD
Amprenavir—Dermatitis—Furosemide—coronary artery disease	4.37e-05	0.00052	CcSEcCtD
Amprenavir—Nausea—Captopril—coronary artery disease	4.36e-05	0.000519	CcSEcCtD
Amprenavir—Headache—Furosemide—coronary artery disease	4.34e-05	0.000517	CcSEcCtD
Amprenavir—Gastrointestinal pain—Lisinopril—coronary artery disease	4.25e-05	0.000506	CcSEcCtD
Amprenavir—Vomiting—Losartan—coronary artery disease	4.25e-05	0.000506	CcSEcCtD
Amprenavir—Nausea—Perindopril—coronary artery disease	4.24e-05	0.000504	CcSEcCtD
Amprenavir—Rash—Losartan—coronary artery disease	4.22e-05	0.000502	CcSEcCtD
Amprenavir—Dermatitis—Losartan—coronary artery disease	4.21e-05	0.000501	CcSEcCtD
Amprenavir—Headache—Losartan—coronary artery disease	4.19e-05	0.000499	CcSEcCtD
Amprenavir—Nausea—Furosemide—coronary artery disease	4.12e-05	0.00049	CcSEcCtD
Amprenavir—Asthenia—Ramipril—coronary artery disease	4.12e-05	0.00049	CcSEcCtD
Amprenavir—Abdominal pain—Lisinopril—coronary artery disease	4.11e-05	0.000489	CcSEcCtD
Amprenavir—Pruritus—Ramipril—coronary artery disease	4.06e-05	0.000483	CcSEcCtD
Amprenavir—Asthenia—Timolol—coronary artery disease	4.02e-05	0.000479	CcSEcCtD
Amprenavir—Nausea—Losartan—coronary artery disease	3.97e-05	0.000473	CcSEcCtD
Amprenavir—Pruritus—Timolol—coronary artery disease	3.97e-05	0.000472	CcSEcCtD
Amprenavir—Diarrhoea—Ramipril—coronary artery disease	3.92e-05	0.000467	CcSEcCtD
Amprenavir—Diarrhoea—Timolol—coronary artery disease	3.84e-05	0.000456	CcSEcCtD
Amprenavir—Asthenia—Lisinopril—coronary artery disease	3.73e-05	0.000444	CcSEcCtD
Amprenavir—Pruritus—Lisinopril—coronary artery disease	3.68e-05	0.000438	CcSEcCtD
Amprenavir—Vomiting—Ramipril—coronary artery disease	3.65e-05	0.000434	CcSEcCtD
Amprenavir—Rash—Ramipril—coronary artery disease	3.62e-05	0.00043	CcSEcCtD
Amprenavir—Dermatitis—Ramipril—coronary artery disease	3.61e-05	0.00043	CcSEcCtD
Amprenavir—Headache—Ramipril—coronary artery disease	3.59e-05	0.000428	CcSEcCtD
Amprenavir—Vomiting—Timolol—coronary artery disease	3.57e-05	0.000424	CcSEcCtD
Amprenavir—Diarrhoea—Lisinopril—coronary artery disease	3.56e-05	0.000423	CcSEcCtD
Amprenavir—Rash—Timolol—coronary artery disease	3.54e-05	0.000421	CcSEcCtD
Amprenavir—Dermatitis—Timolol—coronary artery disease	3.53e-05	0.00042	CcSEcCtD
Amprenavir—Headache—Timolol—coronary artery disease	3.51e-05	0.000418	CcSEcCtD
Amprenavir—Nausea—Ramipril—coronary artery disease	3.41e-05	0.000405	CcSEcCtD
Amprenavir—Nausea—Timolol—coronary artery disease	3.33e-05	0.000396	CcSEcCtD
Amprenavir—Vomiting—Lisinopril—coronary artery disease	3.31e-05	0.000393	CcSEcCtD
Amprenavir—Rash—Lisinopril—coronary artery disease	3.28e-05	0.00039	CcSEcCtD
Amprenavir—Dermatitis—Lisinopril—coronary artery disease	3.28e-05	0.00039	CcSEcCtD
Amprenavir—Headache—Lisinopril—coronary artery disease	3.26e-05	0.000388	CcSEcCtD
Amprenavir—Nausea—Lisinopril—coronary artery disease	3.09e-05	0.000368	CcSEcCtD
Amprenavir—ABCC1—myocardium—coronary artery disease	7.01e-06	0.0558	CbGeAlD
Amprenavir—ABCC1—heart—coronary artery disease	4.89e-06	0.0389	CbGeAlD
Amprenavir—ABCC1—cardiac atrium—coronary artery disease	4.18e-06	0.0333	CbGeAlD
Amprenavir—CYP2B6—heart—coronary artery disease	3.74e-06	0.0297	CbGeAlD
Amprenavir—CYP2C9—heart—coronary artery disease	3.7e-06	0.0294	CbGeAlD
Amprenavir—ABCC1—blood—coronary artery disease	3.65e-06	0.029	CbGeAlD
Amprenavir—CYP2C19—blood—coronary artery disease	3.56e-06	0.0283	CbGeAlD
Amprenavir—CYP2B6—cardiovascular system—coronary artery disease	3.52e-06	0.0281	CbGeAlD
Amprenavir—CYP2C9—cardiovascular system—coronary artery disease	3.49e-06	0.0278	CbGeAlD
Amprenavir—CYP2C8—blood—coronary artery disease	3.11e-06	0.0247	CbGeAlD
Amprenavir—CYP3A5—blood—coronary artery disease	2.8e-06	0.0223	CbGeAlD
Amprenavir—CYP2B6—blood—coronary artery disease	2.79e-06	0.0222	CbGeAlD
Amprenavir—CYP2C9—blood—coronary artery disease	2.76e-06	0.022	CbGeAlD
Amprenavir—ABCC1—Disease—PTGS2—coronary artery disease	2.54e-06	9.27e-05	CbGpPWpGaD
Amprenavir—ABCB1—Metabolism—HMGCR—coronary artery disease	2.52e-06	9.19e-05	CbGpPWpGaD
Amprenavir—ABCB1—Metabolism—GOT2—coronary artery disease	2.52e-06	9.19e-05	CbGpPWpGaD
Amprenavir—CYP3A5—Metabolism—CAT—coronary artery disease	2.52e-06	9.19e-05	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—SLC22A3—coronary artery disease	2.51e-06	9.17e-05	CbGpPWpGaD
Amprenavir—CYP2B6—Metabolism—APOB—coronary artery disease	2.5e-06	9.13e-05	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism—GGT1—coronary artery disease	2.5e-06	9.11e-05	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism—GOT1—coronary artery disease	2.5e-06	9.11e-05	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—HADH—coronary artery disease	2.48e-06	9.03e-05	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—ARNTL—coronary artery disease	2.48e-06	9.03e-05	CbGpPWpGaD
Amprenavir—ABCB1—Transmembrane transport of small molecules—ALB—coronary artery disease	2.47e-06	9.01e-05	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—PSMA6—coronary artery disease	2.45e-06	8.95e-05	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—PSMB5—coronary artery disease	2.45e-06	8.95e-05	CbGpPWpGaD
Amprenavir—CYP3A5—Metabolism—APOB—coronary artery disease	2.45e-06	8.92e-05	CbGpPWpGaD
Amprenavir—CYP2B6—Metabolism—GSTM1—coronary artery disease	2.44e-06	8.88e-05	CbGpPWpGaD
Amprenavir—ABCC1—Metabolism—ALB—coronary artery disease	2.43e-06	8.87e-05	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—PSMA6—coronary artery disease	2.43e-06	8.87e-05	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—PSMB5—coronary artery disease	2.43e-06	8.87e-05	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism of lipids and lipoproteins—ALB—coronary artery disease	2.43e-06	8.85e-05	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—CTGF—coronary artery disease	2.4e-06	8.74e-05	CbGpPWpGaD
Amprenavir—CYP2B6—Metabolism—LPL—coronary artery disease	2.39e-06	8.72e-05	CbGpPWpGaD
Amprenavir—CYP3A5—Metabolism—GSTM1—coronary artery disease	2.38e-06	8.68e-05	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—CTGF—coronary artery disease	2.38e-06	8.66e-05	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—GOT2—coronary artery disease	2.38e-06	8.66e-05	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—HMGCR—coronary artery disease	2.38e-06	8.66e-05	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism—PLCB1—coronary artery disease	2.37e-06	8.66e-05	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—HMGCR—coronary artery disease	2.35e-06	8.59e-05	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—GOT2—coronary artery disease	2.35e-06	8.59e-05	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—GPX2—coronary artery disease	2.35e-06	8.56e-05	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—PLA2G2A—coronary artery disease	2.35e-06	8.56e-05	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—APOA2—coronary artery disease	2.35e-06	8.56e-05	CbGpPWpGaD
Amprenavir—CYP3A5—Metabolism—LPL—coronary artery disease	2.34e-06	8.52e-05	CbGpPWpGaD
Amprenavir—CYP2B6—Metabolism—GPX1—coronary artery disease	2.33e-06	8.5e-05	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—coronary artery disease	2.33e-06	8.49e-05	CbGpPWpGaD
Amprenavir—ABCC1—Metabolism—NOS3—coronary artery disease	2.33e-06	8.49e-05	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—ABCG5—coronary artery disease	2.32e-06	8.46e-05	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—SULT1A1—coronary artery disease	2.32e-06	8.46e-05	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—GPX4—coronary artery disease	2.32e-06	8.46e-05	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—HK1—coronary artery disease	2.32e-06	8.46e-05	CbGpPWpGaD
Amprenavir—ABCB1—Metabolism—PLCB1—coronary artery disease	2.32e-06	8.45e-05	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism—ABCA1—coronary artery disease	2.3e-06	8.39e-05	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—HADHA—coronary artery disease	2.29e-06	8.36e-05	CbGpPWpGaD
Amprenavir—CYP3A5—Metabolism—GPX1—coronary artery disease	2.28e-06	8.31e-05	CbGpPWpGaD
Amprenavir—CYP2B6—Metabolism—CD36—coronary artery disease	2.27e-06	8.28e-05	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—GSTA1—coronary artery disease	2.27e-06	8.26e-05	CbGpPWpGaD
Amprenavir—ABCB1—Metabolism—ABCA1—coronary artery disease	2.25e-06	8.19e-05	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism—GSTP1—coronary artery disease	2.24e-06	8.18e-05	CbGpPWpGaD
Amprenavir—CYP2B6—Metabolism—PPP2CA—coronary artery disease	2.24e-06	8.18e-05	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—LPA—coronary artery disease	2.24e-06	8.17e-05	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism—GGT1—coronary artery disease	2.23e-06	8.13e-05	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism—GOT1—coronary artery disease	2.23e-06	8.13e-05	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism—PPARGC1A—coronary artery disease	2.22e-06	8.1e-05	CbGpPWpGaD
Amprenavir—CYP3A5—Metabolism—CD36—coronary artery disease	2.22e-06	8.09e-05	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism—HMOX1—coronary artery disease	2.21e-06	8.07e-05	CbGpPWpGaD
Amprenavir—CYP3A5—Metabolism—PPP2CA—coronary artery disease	2.19e-06	7.99e-05	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—PLCB1—coronary artery disease	2.18e-06	7.96e-05	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism—CAT—coronary artery disease	2.18e-06	7.96e-05	CbGpPWpGaD
Amprenavir—ABCB1—Metabolism—GGT1—coronary artery disease	2.18e-06	7.93e-05	CbGpPWpGaD
Amprenavir—ABCB1—Metabolism—GOT1—coronary artery disease	2.18e-06	7.93e-05	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—PLCB3—coronary artery disease	2.17e-06	7.91e-05	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—PLCB1—coronary artery disease	2.17e-06	7.9e-05	CbGpPWpGaD
Amprenavir—CYP2B6—Metabolism—MTHFR—coronary artery disease	2.15e-06	7.85e-05	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—APOA5—coronary artery disease	2.15e-06	7.83e-05	CbGpPWpGaD
Amprenavir—ABCC1—Metabolism—PTGS2—coronary artery disease	2.13e-06	7.76e-05	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—coronary artery disease	2.12e-06	7.75e-05	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism—APOB—coronary artery disease	2.12e-06	7.73e-05	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—ABCA1—coronary artery disease	2.12e-06	7.72e-05	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—P4HB—coronary artery disease	2.11e-06	7.68e-05	CbGpPWpGaD
Amprenavir—CYP3A4—blood—coronary artery disease	2.1e-06	0.0168	CbGeAlD
Amprenavir—CYP3A5—Metabolism—MTHFR—coronary artery disease	2.1e-06	7.67e-05	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—ABCA1—coronary artery disease	2.1e-06	7.65e-05	CbGpPWpGaD
Amprenavir—CYP2D6—blood—coronary artery disease	2.07e-06	0.0165	CbGeAlD
Amprenavir—CYP3A4—Metabolism—PLA2G1B—coronary artery disease	2.07e-06	7.54e-05	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism—GSTM1—coronary artery disease	2.06e-06	7.52e-05	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—GGT1—coronary artery disease	2.05e-06	7.48e-05	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—GOT1—coronary artery disease	2.05e-06	7.48e-05	CbGpPWpGaD
Amprenavir—CYP2B6—Metabolism—AGT—coronary artery disease	2.04e-06	7.46e-05	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—GGT1—coronary artery disease	2.03e-06	7.41e-05	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—GOT1—coronary artery disease	2.03e-06	7.41e-05	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism—LPL—coronary artery disease	2.02e-06	7.38e-05	CbGpPWpGaD
Amprenavir—CYP2B6—Metabolism—APOE—coronary artery disease	2e-06	7.31e-05	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism—GSTP1—coronary artery disease	2e-06	7.3e-05	CbGpPWpGaD
Amprenavir—CYP3A5—Metabolism—AGT—coronary artery disease	2e-06	7.29e-05	CbGpPWpGaD
Amprenavir—ABCB1—heart—coronary artery disease	2e-06	0.0159	CbGeAlD
Amprenavir—CYP2C19—Metabolism—PPARGC1A—coronary artery disease	1.98e-06	7.23e-05	CbGpPWpGaD
Amprenavir—CYP2B6—Metabolism—APOA1—coronary artery disease	1.98e-06	7.22e-05	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism—HMOX1—coronary artery disease	1.97e-06	7.2e-05	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism—GPX1—coronary artery disease	1.97e-06	7.2e-05	CbGpPWpGaD
Amprenavir—CYP3A5—Metabolism—APOE—coronary artery disease	1.96e-06	7.14e-05	CbGpPWpGaD
Amprenavir—ABCB1—Metabolism—GSTP1—coronary artery disease	1.95e-06	7.13e-05	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—VCAN—coronary artery disease	1.95e-06	7.11e-05	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism—CAT—coronary artery disease	1.95e-06	7.11e-05	CbGpPWpGaD
Amprenavir—ABCB1—Metabolism—PPARGC1A—coronary artery disease	1.94e-06	7.06e-05	CbGpPWpGaD
Amprenavir—CYP3A5—Metabolism—APOA1—coronary artery disease	1.94e-06	7.06e-05	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—ALDOA—coronary artery disease	1.93e-06	7.05e-05	CbGpPWpGaD
Amprenavir—ABCB1—Metabolism—HMOX1—coronary artery disease	1.93e-06	7.03e-05	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism—CD36—coronary artery disease	1.92e-06	7.01e-05	CbGpPWpGaD
Amprenavir—ABCB1—Metabolism—CAT—coronary artery disease	1.9e-06	6.94e-05	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism—PPP2CA—coronary artery disease	1.9e-06	6.92e-05	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism—APOB—coronary artery disease	1.89e-06	6.9e-05	CbGpPWpGaD
Amprenavir—ABCB1—cardiovascular system—coronary artery disease	1.88e-06	0.015	CbGeAlD
Amprenavir—CYP3A4—Metabolism—DCN—coronary artery disease	1.88e-06	6.85e-05	CbGpPWpGaD
Amprenavir—ABCB1—Metabolism—APOB—coronary artery disease	1.85e-06	6.73e-05	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—GSTP1—coronary artery disease	1.84e-06	6.72e-05	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism—GSTM1—coronary artery disease	1.84e-06	6.71e-05	CbGpPWpGaD
Amprenavir—ABCC1—Disease—TGFB1—coronary artery disease	1.84e-06	6.7e-05	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—ALDH2—coronary artery disease	1.83e-06	6.66e-05	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—GSTP1—coronary artery disease	1.83e-06	6.66e-05	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—PPARGC1A—coronary artery disease	1.82e-06	6.65e-05	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism—MTHFR—coronary artery disease	1.82e-06	6.64e-05	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—HMOX1—coronary artery disease	1.82e-06	6.62e-05	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—PPARGC1A—coronary artery disease	1.81e-06	6.6e-05	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism—LPL—coronary artery disease	1.81e-06	6.59e-05	CbGpPWpGaD
Amprenavir—ABCC1—Disease—MAPK1—coronary artery disease	1.8e-06	6.57e-05	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—HMOX1—coronary artery disease	1.8e-06	6.57e-05	CbGpPWpGaD
Amprenavir—ABCB1—Metabolism—GSTM1—coronary artery disease	1.8e-06	6.55e-05	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—CAT—coronary artery disease	1.79e-06	6.54e-05	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—HBA1—coronary artery disease	1.78e-06	6.49e-05	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—LIPC—coronary artery disease	1.78e-06	6.49e-05	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—PIK3C2A—coronary artery disease	1.78e-06	6.49e-05	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—CYP2C19—coronary artery disease	1.78e-06	6.49e-05	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—CAT—coronary artery disease	1.78e-06	6.48e-05	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—APOC3—coronary artery disease	1.77e-06	6.45e-05	CbGpPWpGaD
Amprenavir—ABCB1—Metabolism—LPL—coronary artery disease	1.76e-06	6.43e-05	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism—GPX1—coronary artery disease	1.76e-06	6.43e-05	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—LDLR—coronary artery disease	1.76e-06	6.41e-05	CbGpPWpGaD
Amprenavir—CYP2B6—Metabolism—PPARG—coronary artery disease	1.75e-06	6.36e-05	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—APOB—coronary artery disease	1.74e-06	6.34e-05	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—SLC9A1—coronary artery disease	1.74e-06	6.33e-05	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—GSTT1—coronary artery disease	1.74e-06	6.33e-05	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism—AGT—coronary artery disease	1.73e-06	6.31e-05	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—APOB—coronary artery disease	1.72e-06	6.29e-05	CbGpPWpGaD
Amprenavir—CYP2B6—Metabolism—POMC—coronary artery disease	1.72e-06	6.28e-05	CbGpPWpGaD
Amprenavir—ABCB1—Metabolism—GPX1—coronary artery disease	1.72e-06	6.27e-05	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—GCLC—coronary artery disease	1.72e-06	6.26e-05	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—CETP—coronary artery disease	1.72e-06	6.26e-05	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism—CD36—coronary artery disease	1.72e-06	6.26e-05	CbGpPWpGaD
Amprenavir—CYP3A5—Metabolism—PPARG—coronary artery disease	1.71e-06	6.22e-05	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—SDC1—coronary artery disease	1.7e-06	6.19e-05	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism—APOE—coronary artery disease	1.7e-06	6.19e-05	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism—PPP2CA—coronary artery disease	1.69e-06	6.18e-05	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—GSTM1—coronary artery disease	1.69e-06	6.17e-05	CbGpPWpGaD
Amprenavir—CYP3A5—Metabolism—POMC—coronary artery disease	1.68e-06	6.13e-05	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—GSTM1—coronary artery disease	1.68e-06	6.12e-05	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism—APOA1—coronary artery disease	1.68e-06	6.11e-05	CbGpPWpGaD
Amprenavir—ABCB1—Metabolism—CD36—coronary artery disease	1.68e-06	6.11e-05	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—LPL—coronary artery disease	1.66e-06	6.06e-05	CbGpPWpGaD
Amprenavir—ABCB1—Metabolism—PPP2CA—coronary artery disease	1.65e-06	6.03e-05	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—LPL—coronary artery disease	1.65e-06	6.01e-05	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism—MTHFR—coronary artery disease	1.63e-06	5.93e-05	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—GPX1—coronary artery disease	1.62e-06	5.91e-05	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—GPX1—coronary artery disease	1.61e-06	5.86e-05	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—coronary artery disease	1.61e-06	5.85e-05	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—PSMA6—coronary artery disease	1.6e-06	5.85e-05	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—PSMB5—coronary artery disease	1.6e-06	5.85e-05	CbGpPWpGaD
Amprenavir—ABCB1—Metabolism—MTHFR—coronary artery disease	1.59e-06	5.79e-05	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—CD36—coronary artery disease	1.58e-06	5.76e-05	CbGpPWpGaD
Amprenavir—CYP2B6—Metabolism—ALB—coronary artery disease	1.57e-06	5.72e-05	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—CTGF—coronary artery disease	1.57e-06	5.71e-05	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—CD36—coronary artery disease	1.56e-06	5.71e-05	CbGpPWpGaD
Amprenavir—ABCC1—Disease—PIK3CA—coronary artery disease	1.56e-06	5.7e-05	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—PPP2CA—coronary artery disease	1.56e-06	5.68e-05	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—HMGCR—coronary artery disease	1.55e-06	5.66e-05	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—GOT2—coronary artery disease	1.55e-06	5.66e-05	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—PPP2CA—coronary artery disease	1.55e-06	5.63e-05	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism—AGT—coronary artery disease	1.55e-06	5.63e-05	CbGpPWpGaD
Amprenavir—CYP3A5—Metabolism—ALB—coronary artery disease	1.53e-06	5.59e-05	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism—APOE—coronary artery disease	1.51e-06	5.52e-05	CbGpPWpGaD
Amprenavir—ABCB1—Metabolism—AGT—coronary artery disease	1.51e-06	5.5e-05	CbGpPWpGaD
Amprenavir—CYP2B6—Metabolism—NOS3—coronary artery disease	1.5e-06	5.47e-05	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism—APOA1—coronary artery disease	1.5e-06	5.46e-05	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—MTHFR—coronary artery disease	1.5e-06	5.45e-05	CbGpPWpGaD
Amprenavir—ABCB1—blood—coronary artery disease	1.49e-06	0.0119	CbGeAlD
Amprenavir—CYP2C9—Metabolism—MTHFR—coronary artery disease	1.48e-06	5.41e-05	CbGpPWpGaD
Amprenavir—ABCB1—Metabolism—APOE—coronary artery disease	1.48e-06	5.39e-05	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism—PPARG—coronary artery disease	1.48e-06	5.39e-05	CbGpPWpGaD
Amprenavir—CYP3A5—Metabolism—NOS3—coronary artery disease	1.47e-06	5.35e-05	CbGpPWpGaD
Amprenavir—ABCB1—Metabolism—APOA1—coronary artery disease	1.46e-06	5.33e-05	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism—POMC—coronary artery disease	1.46e-06	5.31e-05	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—coronary artery disease	1.43e-06	5.23e-05	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—PLCB1—coronary artery disease	1.43e-06	5.21e-05	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—AGT—coronary artery disease	1.42e-06	5.18e-05	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—AGT—coronary artery disease	1.41e-06	5.14e-05	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—APOE—coronary artery disease	1.39e-06	5.08e-05	CbGpPWpGaD
Amprenavir—ABCC1—Disease—IL6—coronary artery disease	1.38e-06	5.05e-05	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—ABCA1—coronary artery disease	1.38e-06	5.05e-05	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—APOE—coronary artery disease	1.38e-06	5.03e-05	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—APOA1—coronary artery disease	1.38e-06	5.02e-05	CbGpPWpGaD
Amprenavir—CYP2B6—Metabolism—PTGS2—coronary artery disease	1.37e-06	5.01e-05	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—APOA1—coronary artery disease	1.36e-06	4.98e-05	CbGpPWpGaD
Amprenavir—CYP3A5—Metabolism—PTGS2—coronary artery disease	1.34e-06	4.89e-05	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—GGT1—coronary artery disease	1.34e-06	4.89e-05	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—GOT1—coronary artery disease	1.34e-06	4.89e-05	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism—ALB—coronary artery disease	1.33e-06	4.84e-05	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism—PPARG—coronary artery disease	1.32e-06	4.81e-05	CbGpPWpGaD
Amprenavir—ABCC1—Metabolism—PIK3CA—coronary artery disease	1.31e-06	4.77e-05	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—coronary artery disease	1.31e-06	4.77e-05	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism—POMC—coronary artery disease	1.3e-06	4.74e-05	CbGpPWpGaD
Amprenavir—ABCB1—Metabolism—PPARG—coronary artery disease	1.29e-06	4.69e-05	CbGpPWpGaD
Amprenavir—ABCC1—Disease—AKT1—coronary artery disease	1.28e-06	4.66e-05	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism—NOS3—coronary artery disease	1.27e-06	4.63e-05	CbGpPWpGaD
Amprenavir—ABCB1—Metabolism—POMC—coronary artery disease	1.27e-06	4.63e-05	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—PPARG—coronary artery disease	1.21e-06	4.42e-05	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—GSTP1—coronary artery disease	1.2e-06	4.39e-05	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—PPARG—coronary artery disease	1.2e-06	4.38e-05	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—POMC—coronary artery disease	1.2e-06	4.36e-05	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—PPARGC1A—coronary artery disease	1.19e-06	4.35e-05	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—HMOX1—coronary artery disease	1.19e-06	4.33e-05	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—POMC—coronary artery disease	1.19e-06	4.32e-05	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism—ALB—coronary artery disease	1.19e-06	4.32e-05	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—CAT—coronary artery disease	1.17e-06	4.27e-05	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism—PTGS2—coronary artery disease	1.16e-06	4.24e-05	CbGpPWpGaD
Amprenavir—ABCB1—Metabolism—ALB—coronary artery disease	1.16e-06	4.22e-05	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—APOB—coronary artery disease	1.14e-06	4.15e-05	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism—NOS3—coronary artery disease	1.13e-06	4.14e-05	CbGpPWpGaD
Amprenavir—ABCB1—Metabolism—NOS3—coronary artery disease	1.11e-06	4.04e-05	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—GSTM1—coronary artery disease	1.11e-06	4.04e-05	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—ALB—coronary artery disease	1.09e-06	3.98e-05	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—LPL—coronary artery disease	1.09e-06	3.96e-05	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—ALB—coronary artery disease	1.08e-06	3.94e-05	CbGpPWpGaD
Amprenavir—ABCC1—Metabolism—AKT1—coronary artery disease	1.07e-06	3.9e-05	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—GPX1—coronary artery disease	1.06e-06	3.86e-05	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—NOS3—coronary artery disease	1.04e-06	3.8e-05	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism—PTGS2—coronary artery disease	1.04e-06	3.78e-05	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—NOS3—coronary artery disease	1.03e-06	3.77e-05	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—CD36—coronary artery disease	1.03e-06	3.76e-05	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—PPP2CA—coronary artery disease	1.02e-06	3.72e-05	CbGpPWpGaD
Amprenavir—ABCB1—Metabolism—PTGS2—coronary artery disease	1.01e-06	3.69e-05	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—MTHFR—coronary artery disease	9.78e-07	3.57e-05	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—PTGS2—coronary artery disease	9.54e-07	3.48e-05	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—PTGS2—coronary artery disease	9.46e-07	3.45e-05	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—AGT—coronary artery disease	9.29e-07	3.39e-05	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—APOE—coronary artery disease	9.1e-07	3.32e-05	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—APOA1—coronary artery disease	9e-07	3.28e-05	CbGpPWpGaD
Amprenavir—CYP2B6—Metabolism—PIK3CA—coronary artery disease	8.45e-07	3.08e-05	CbGpPWpGaD
Amprenavir—CYP3A5—Metabolism—PIK3CA—coronary artery disease	8.26e-07	3.01e-05	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—PPARG—coronary artery disease	7.93e-07	2.89e-05	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—POMC—coronary artery disease	7.82e-07	2.85e-05	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism—PIK3CA—coronary artery disease	7.15e-07	2.61e-05	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—ALB—coronary artery disease	7.13e-07	2.6e-05	CbGpPWpGaD
Amprenavir—CYP2B6—Metabolism—AKT1—coronary artery disease	6.9e-07	2.52e-05	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—NOS3—coronary artery disease	6.82e-07	2.49e-05	CbGpPWpGaD
Amprenavir—CYP3A5—Metabolism—AKT1—coronary artery disease	6.74e-07	2.46e-05	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism—PIK3CA—coronary artery disease	6.38e-07	2.33e-05	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—PTGS2—coronary artery disease	6.24e-07	2.27e-05	CbGpPWpGaD
Amprenavir—ABCB1—Metabolism—PIK3CA—coronary artery disease	6.23e-07	2.27e-05	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—PIK3CA—coronary artery disease	5.87e-07	2.14e-05	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism—AKT1—coronary artery disease	5.84e-07	2.13e-05	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—PIK3CA—coronary artery disease	5.82e-07	2.12e-05	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism—AKT1—coronary artery disease	5.21e-07	1.9e-05	CbGpPWpGaD
Amprenavir—ABCB1—Metabolism—AKT1—coronary artery disease	5.09e-07	1.86e-05	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—AKT1—coronary artery disease	4.8e-07	1.75e-05	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—AKT1—coronary artery disease	4.75e-07	1.73e-05	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—PIK3CA—coronary artery disease	3.84e-07	1.4e-05	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—AKT1—coronary artery disease	3.14e-07	1.14e-05	CbGpPWpGaD
